Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Rakshit · SciRah

Researcher profile · Semantic Scholar

S. Rakshit

Share profile

S. Rakshit — researcher profile on SciRah

h-index: 17
Works: 43
Citations: 1,674

Most-cited papers

Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death‐Ligand 1 Inhibitors in Non‐Small Cell Lung Cancer: A Systematic Review and Meta‐Analysis of Trials
Monica Khunger, S. Rakshit, V. Pasupuleti, A. V. Hernández +4 more
2017Chest473 citations
Semantic Scholar
Perinodular and Intranodular Radiomic Features on Lung CT Images Distinguish Adenocarcinomas from Granulomas
N. Beig, Mohammadhadi Khorrami, M. Alilou, P. Prasanna +15 more
2018Radiology302 citations Open access
Semantic Scholar
Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology
J. Dolezal, Andrew Srisuwananukorn, D. Karpeyev, S. Ramesh +12 more
2022Nature Communications169 citations Open access
Semantic Scholar
Programmed Cell Death 1 (PD-1) Ligand (PD-L1) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1/PD-L1 Axis Inhibitors: A Systematic Review and Meta-Analysis.
Monica Khunger, A. V. Hernández, V. Pasupuleti, S. Rakshit +5 more
2017JCO Precision Oncology112 citations
Semantic Scholar
Extramedullary disease in multiple myeloma
R. Bansal, S. Rakshit, Shaji K. Kumar
2021Blood Cancer Journal98 citations Open access
Semantic Scholar
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients
Monica Khunger, P. Patil, A. Khunger, Man-Shi Li +8 more
2018PLoS ONE72 citations Open access
Semantic Scholar
Safety and Efficacy of PD‐1/PD‐L1 Inhibitors in Treatment‐Naive and Chemotherapy‐Refractory Patients With Non–Small‐Cell Lung Cancer: A Systematic Review and Meta‐Analysis
Monica Khunger, P. Jain, S. Rakshit, V. Pasupuleti +4 more
2018Clinical Lung Cancer52 citations Open access
Semantic Scholar
An integrated segmentation and shape-based classification scheme for distinguishing adenocarcinomas from granulomas on lung CT
M. Alilou, N. Beig, M. Orooji, P. Rajiah +8 more
2017Medical Physics (Lancaster)46 citations Open access
Semantic Scholar
Ipilimumab-induced colitis in patients with metastatic melanoma
K. D. De Felice, Arjun Gupta, S. Rakshit, S. Khanna +6 more
2015Melanoma research44 citations
Semantic Scholar
Incidence of pneumonitis with use of PD-1 and PD-L1 inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of trials.
Monica Khunger, V. Pasupuleti, S. Rakshit, P. Jain +5 more
201735 citations
Semantic Scholar
Immunotherapy in patients with autoimmune disease
S. Rakshit, J. Molina
2020Journal of Thoracic Disease30 citations Open access
Semantic Scholar
Combination of computer extracted shape and texture features enables discrimination of granulomas from adenocarcinoma on chest computed tomography
M. Orooji, M. Alilou, S. Rakshit, N. Beig +11 more
2018Journal of Medical Imaging30 citations Open access
Semantic Scholar
Neutrophil to lymphocyte ratio as a prognostic marker in metastatic gallbladder cancer.
Mohamed Mady, Kritika Prasai, S. Tella, S. Yadav +5 more
2020HPB28 citations Open access
Semantic Scholar
Supplementary Information for “ Quantitative vessel tortuosity : A potential CT imaging biomarker for distinguishing lung granulomas from adenocarcinomas ”
M. Alilou, M. Orooji, N. Beig, P. Prasanna +11 more
201828 citations
Semantic Scholar
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report.
A. Desai, S. Rakshit, R. Bansal, Y. Ashara +16 more
2023Cancer Treatment and Research Communications25 citations Open access
Semantic Scholar
Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint Inhibitors.
Monica Khunger, S. Rakshit, A. V. Hernández, V. Pasupuleti +3 more
2018The Oncologist24 citations Open access
Semantic Scholar
Programmed Cell Death 1 ( PD-1 ) Ligand ( PD-L 1 ) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1 / PD-L 1 Axis Inhibitors : A Systematic Review and Meta-Analysis
Monica Khunger, A. V. Hernández, V. Pasupuleti, S. Rakshit +5 more
201718 citations
Semantic Scholar
Correlation of Somatostatin Receptor 2 Expression, 68Ga-DOTATATE PET Scan and Octreotide Treatment in Thymic Epithelial Tumors
A. Roden, S. Rakshit, G. Johnson, Sarah M. Jenkins +1 more
2022Frontiers in Oncology17 citations Open access
Semantic Scholar
Immune‐related hematologic adverse events in the context of immune checkpoint inhibitor therapy
Antoine N. Saliba, Zhuoer Xie, A. Higgins, X. Andrade-Gonzalez +21 more
2021American journal of hematology/oncology11 citations Open access
Semantic Scholar
Pre-treatment hematological markers as a predictive biomarker for survival in patients with non-small cell lung cancer treated with nivolumab.
P. Patil, Monica Khunger, S. Rakshit, J. Stevenson +3 more
201710 citations
Semantic Scholar
Meta-analysis of tumor PD-L1 expression as a predictive biomarker of benefit from PD-1/PD-L1 axis inhibitors in solid tumors.
Monica Khunger, S. Rakshit, K. Schalper, P. Elson +3 more
20168 citations
Semantic Scholar
Durable Response to Combination of Dabrafenib and Trametinib in BRAF V600E-Mutated Non-small-cell Lung Cancer.
L. M. Pervere, S. Rakshit, A. Schrock, V. Miller +2 more
2017Clinical Lung Cancer7 citations
Semantic Scholar
Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies
Zhuoer Xie, Antoine N. Saliba, J. Abeykoon, U. Majeed +25 more
2021JCO Oncology Practice6 citations Open access
Semantic Scholar
MA13.09 Time from Immune Checkpoint Inhibitor to Sotorasib Use Correlates with Risk of Hepatotoxicity in Non-small Cell Lung Cancer
S. Rakshit, R. Bansal, A. Potter, R. Manochakian +13 more
2022Journal of Thoracic Oncology5 citations Open access
Semantic Scholar
21P The landscape of ALK alterations in non-small cell lung cancer
A. Desai, T. Mohammed, S. Rakshit, J. Krull
20215 citations
Semantic Scholar
Quantitative vessel tortuosity: A potential CT imaging biomarker for distinguishing lung granulomas from adenocarcinomas
M. Alilou, Mahdi Orooji, N. Beig, P. Prasanna +9 more
2018Scientific Reports5 citations Open access
Semantic Scholar
Evaluation of radiomic features on baseline CT scan to predict clinical benefit for pemetrexed based chemotherapy in metastatic lung adenocarcinoma.
S. Rakshit, M. Orooji, N. Beig, M. Alilou +5 more
20165 citations
Semantic Scholar
Computerized textural analysis of lung CT to enable quantification of tumor infiltrating lymphocytes in NSCLC.
M. Orooji, S. Rakshit, N. Beig, A. Madabhushi +1 more
20163 citations
Semantic Scholar
38P Brain metastases in non-small cell lung cancer in era of molecularly driven therapy
S. Rakshit, R. Bansal, A. Desai, K. Leventakos
20212 citations
Semantic Scholar
Factors Associated with Renal Impairment at Diagnosis in Multiple Myeloma with Survival Trends over Last Two Decades
S. Rakshit, R. Bansal, P. Kapoor, A. Dispenzieri +16 more
2021Blood2 citations Open access
Semantic Scholar
The use of artificial intelligence with uncertainty estimation to predict lung cancer relapse from histopathology.
J. Dolezal, S. Kochanny, A-Kao Zhu, S. Rakshit +7 more
2022Journal of Clinical Oncology1 citations
Semantic Scholar
Abstract S06-03: Outcomes of COVID-19 in patients with cancer: Results of a prospective observational comparison of routine screening strategy versus testing based on clinical suspicion
Zhuoer Xie, Antoine N. Saliba, J. Abeykoon, U. Majeed +22 more
2021Oral Presentations - Proffered Abstracts1 citations
Semantic Scholar
Modulation of Apoptosis Pathways in the Biology and Treatment of Multiple Myeloma
R. Bansal, S. Rakshit, W. Han, Shaji K. Kumar
2021Oncology & Haematology1 citations Open access
Semantic Scholar
Immune-Related Hematologic Adverse Events in the Context of Checkpoint Inhibitors
Antoine N. Saliba, Zhuoer Xie, A. Higgins, X. Andrade-Gonzalez +19 more
20201 citations
Semantic Scholar
Author Correction: Quantitative vessel tortuosity: A potential CT imaging biomarker for distinguishing lung granulomas from adenocarcinomas
M. Alilou, M. Orooji, N. Beig, P. Prasanna +9 more
2019Scientific Reports1 citations Open access
Semantic Scholar
Premature clinical trial discontinuation in all and genitourinary (GU) cancers in the era of immune checkpoint inhibitors (ICI).
Monica Khunger, S. Rakshit, K. Tullio, M. Galsky +1 more
20171 citations
Semantic Scholar
Opportunities for lung cancer screening: A prospective cross-sectional study of patients with lung cancer treated at an academic cancer center.
A. Pemmaraju, M. Neumann, S. Rakshit, S. Rajan +2 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
OA08.01 Trends in Within-Class Changes in US Prices of Drugs used for Metastatic Non-Small Cell Lung Cancer from 2015 to 2020
A. Desai, C. Jensen, C. Scheckel, J. Orme +5 more
2021Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
P26.04 Correlation of Somatostatin Receptor 2 Expression, DOTATATE scan and Octreotide Treatment in Thymic Epithelial Tumors
A. Roden, S. Rakshit, G. Johnson, A. Mansfield
20210 citations Open access
Semantic Scholar
Comparison of Conventional Xrays with CT Based Approaches for Detection of Lytic Lesions in Multiple Myeloma
R. Bansal, S. Rakshit, K. Glazebrook, P. Kapoor +19 more
20200 citations
Semantic Scholar
Pre-clinical proof of principle of pharmacologically rational non-cytotoxic epigenetic-immunotherapy to treat lung cancer.
Kai Kang, S. Rakshit, K. Schalper, N. Pennell +3 more
20160 citations
Semantic Scholar
Preoperative neutrophil lymphocyte ratio as a predictor of outcomes in patients with early stage non-small cell lung cancer.
P. Patil, S. Rakshit, Arnab Basu, N. Pennell +5 more
20160 citations
Semantic Scholar
Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer
V. Velcheti, N. Pennell, S. Rakshit, J. Stevenson +5 more
2015Journal of Immunotherapy for Cancer0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Velcheti×20
Invite
V. Velcheti — researcher profile on SciRah
N. Pennell×12
Invite
N. Pennell — researcher profile on SciRah
J. Stevenson×11
Invite
J. Stevenson — researcher profile on SciRah
Monica Khunger×10
Invite
Monica Khunger — researcher profile on SciRah

×8

Invite

N. Beig — researcher profile on SciRah

A. Madabhushi×8

Invite

A. Madabhushi — researcher profile on SciRah

Invite

M. Alilou — researcher profile on SciRah

Invite

M. Orooji — researcher profile on SciRah

Invite

R. Bansal — researcher profile on SciRah

V. Pasupuleti×6

Invite

V. Pasupuleti — researcher profile on SciRah

A. V. Hernández×6

Invite

A. V. Hernández — researcher profile on SciRah

Invite

P. Rajiah — researcher profile on SciRah